I now have comprehensive information to write a thorough 10-mark MS ENT exam answer. Here is the complete answer:
SLAD-R Procedure (Selective Laryngeal Adductor Denervation-Reinnervation)
Definition
SLAD-R stands for Selective Laryngeal Adductor Denervation-Reinnervation. It is a surgical procedure for the treatment of Adductor Spasmodic Dysphonia (ADSD), a focal laryngeal dystonia characterized by spasmodic adduction of the vocal folds during speech, producing a strained, strangled voice quality with voice breaks.
Background / Historical Context
- Spasmodic dysphonia was first described by Traube (1871); recognized as a focal dystonia by Fraenkel and Gowers.
- ADSD accounts for ~80% of all laryngeal dystonia cases. ABSD (abductor type) accounts for ~20%.
- Earlier surgical treatment: Dedo's RLN section - initially promising but at 3-year follow-up, only 36% showed persistent improvement and only 3% achieved a normal voice (Aronson & DeSanto).
- SLAD-R was developed by Dr. Gerald Berke at UCLA in the late 1990s, based on in vivo canine studies, to overcome the failures of the Dedo operation.
Rationale / Concept
The key concept is selective denervation - targeting only the adductor branch of the RLN (supplying TA and LCA muscles) while preserving the abductor branch (supplying posterior cricoarytenoid), then reinnervating with ansa cervicalis to:
- Eliminate dystonic nerve impulses causing adductory spasms.
- Prevent permanent vocal fold paralysis and paresis.
- Provide tonic, non-dystonic neural input for muscle bulk maintenance.
The standard of care for ADSD is botulinum toxin (BoNT) injection, but disadvantages include need for repeated injections, unpredictable breathiness, and lack of uniform dose-response. SLAD-R offers a long-lasting surgical alternative.
Indications
- Confirmed diagnosis of Adductor Spasmodic Dysphonia (ADSD)
- Patients not satisfied with or not responding adequately to botulinum toxin therapy
- Young patients who find repeated injections difficult to maintain
- Patients seeking a more permanent solution
Contraindications / Patient Selection
- Abductor SD (ABSD) - procedure is not appropriate
- Mixed laryngeal dystonia with significant abductor component
- Generalized neurological conditions (Parkinson's, MND, MS, myasthenia gravis) must be excluded before surgery
- Prior failed RLN section (Dedo procedure) - requires careful evaluation
Surgical Technique (Step-by-Step)
Anesthesia and Setup:
- General anesthesia with an EMG-monitoring endotracheal tube (NIM-Response System, Medtronic Xomed) for intraoperative RLN monitoring
- Bed turned 90° from anesthesiologist; surgeon stands at head of bed
- Shoulder roll placed to extend the neck
- Preoperative IV dexamethasone 10 mg + prophylactic antibiotics
The procedure is performed bilaterally (each side in sequence):
Step 1 - Neck incision and exposure:
- Horizontal neck incision (similar to thyroidectomy)
- Platysma divided, subplatysmal flaps raised
- Strap muscles retracted to expose the thyroid gland and trachea
Step 2 - RLN identification:
- The Recurrent Laryngeal Nerve (RLN) is identified as it enters the larynx
- Intraoperative EMG monitoring confirms RLN activity
Step 3 - Selective adductor branch denervation:
- The anterior (adductor) branch of the RLN is identified - this supplies the Thyroarytenoid (TA) and Lateral Cricoarytenoid (LCA) muscles
- The adductor branch is sectioned (cut and a segment removed to prevent reattachment)
- The posterior (abductor) branch supplying the Posterior Cricoarytenoid (PCA) muscle is carefully preserved to maintain abductory function
Step 4 - Ansa cervicalis harvest:
- A branch of the ansa cervicalis nerve (typically the branch to the sternohyoid or omohyoid) is identified and dissected
- This nerve supplies less critical infrahyoid strap muscles
Step 5 - Reinnervation (neurorrhaphy):
- The harvested ansa cervicalis branch is anastomosed (nerve-to-nerve) to the distal cut end of the adductor RLN branch using microsurgical technique (9-0 or 10-0 nylon suture under microscope)
- This provides tonic, non-dystonic reinnervation to the TA and LCA muscles
- It prevents differential reinnervation by residual dystonic axons
Step 6 - Optional LCA myotomy:
- A conservative LCA myotomy may be performed to reduce the risk of postoperative breathiness (in select cases)
- This was introduced to minimize the complication of permanent breathiness
Step 7 - Wound closure:
- Standard layered closure
- Procedure repeated on the contralateral side
Postoperative Voice Changes
| Phase | Voice Quality |
|---|
| Immediate post-op | Breathy, whispery (expected) |
| 3-6 months | Gradual return of voice tone as reinnervation matures |
| 6-12 months | Near-normal or normal fluent voice in majority |
Reinnervation takes 3 or more months, during which patients have a breathy voice. This must be counseled preoperatively.
Results and Outcomes
Based on the long-term UCLA series:
- 83% of patients showed significantly improved Vocal Handicap Index-10 (VHI-10) scores at average follow-up of 49 months
- 91% reported their post-surgery voice was more fluent than after Botox therapy
- Initial series (Berke, 1999): 19 of 21 patients had absent to mild voice breaks postoperatively
- Patient satisfaction is high; results are long-lasting (the only surgical treatment for ADSD with demonstrated long-term control)
Complications
| Complication | Rate |
|---|
| Transient breathiness (expected, self-limiting) | Universal |
| Recurrence of dystonia (true failure) | ~11% |
| Moderate permanent breathiness | ~14% |
| Severe permanent breathiness / vocal cord paresis | ~6% |
| Recurrence pattern | Within 12-24 months if it occurs |
| Rare: Bilateral vocal fold paralysis | Reported (can require total laryngectomy in extreme cases) |
| Swallowing difficulty (transient) | Occasional |
- Recurrent symptoms after failure respond to botulinum toxin injections
- Conservative LCA myotomy has minimized the rate of severe permanent breathiness
Comparison with Other Treatments for ADSD
| Treatment | Advantage | Disadvantage |
|---|
| Botulinum toxin (standard of care) | Predictable, non-surgical | Repeated injections, temporary, dose variability |
| Dedo RLN section | Simple | High recurrence (>60% at 3 years), permanent paresis |
| Isshiki Thyroplasty Type II | No nerve work | Less evidence |
| CO2 laser TA myoneurectomy | Endoscopic | Limited data |
| SLAD-R | Long-lasting, high satisfaction | Breathy recovery phase, specialized centers only |
Key Points to Remember (Exam Summary)
- SLAD-R = Selective Laryngeal Adductor Denervation-Reinnervation
- For ADSD only (NOT abductor SD)
- Developed by Gerald Berke, UCLA, late 1990s
- Denervation: anterior branch of RLN (TA + LCA) - preserving posterior branch (PCA)
- Reinnervation: ansa cervicalis nerve anastomosed to distal adductor branch
- Bilateral procedure under EMG-guided intubation
- Post-op: breathy voice for 3+ months during reinnervation
- Outcomes: 83-91% improvement, long-lasting
- Key complication: ~11% recurrence, ~14% permanent breathiness
- Only surgical treatment with demonstrated long-term symptom control for ADSD
Sources: Cummings Otolaryngology Head and Neck Surgery; Scott-Brown's Otorhinolaryngology Head & Neck Surgery; Chhetri & Berke, UCLA SLAD-R Surgical Technique